as on February 6, 2026 at 2:29 am IST
Day's Low
Day's High
1.43%
Downside
15.05%
Upside
52 Week's Low
52 Week's High
32.24%
Downside
133.51%
Upside
Check Abcellera Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-0.6525
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.46%
PE Ratio (TTM)
-4.86
Industry PE ratio
-1.8111934156378602
PEG Ratio
0EBITDA
-232.7M
Revenue (TTM)
35.3M
Profit Margin
0.00%
Return On Equity TTM
-16.81%
Track how Abcellera Biologics Inc P/E has moved over time to understand its valuation trends.
Abcellera Biologics Inc in the last 5 years
Lowest (-50.45x)
March 31, 2023
Today (-4.86x)
February 5, 2026
Industry (-1.81x)
February 5, 2026
Highest (52.65x)
March 31, 2021
Today’s Price to Earnings Ratio: -4.86x
Compare market cap, revenue, PE, and other key metrics of Abcellera Biologics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.2B | -92.98% | -4.86 | 0.00% | |
| BUY | $47.7B | 113.17% | 1246.03 | 1.36% | |
| BUY | $122.3B | 118.58% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 55.33% | 18.28 | 32.13% |
The Abcellera Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Abcellera Biologics Inc investment value today
Current value as on today
₹85,913
Returns
Returns from Abcellera Biologics Inc Stock
Dollar Returns*
₹3,368 (+3.37%)
Based on 15 analysts
93.33%
Buy
6.67%
Hold
0.00%
Sell
Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Abcellera Biologics Inc. Average target price of $9.83
Get share price movements and forecasts by analysts on Abcellera Biologics Inc.
What analysts predicted
71.62%UPSIDE
Target Price
$9.83
Current Price
$2.79
Analyzed by
15 Analysts
Target
$9.83
Abcellera Biologics Inc target price $9.83, a slight upside of 71.62% compared to current price of $2.79. According to 15 analysts rating.
Search interest for Abcellera Biologics Inc Stock has increased by 239% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:239% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 43.6% return, outperforming this stock by 113.8%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 53.8% return, outperforming this stock by 54.4%
Price Dip
![]()
In the last 7 days, ABCL stock has moved down by -9.7%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -34.72M → -57.11M (in $), with an average decrease of 64.5% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 17.08M → 8.95M (in $), with an average decrease of 47.6% per quarter
| Organisation | Abcellera Biologics Inc |
| Headquarters | 150 West 4th Ave, Vancouver, BC, Canada, V5Y 1G6 |
| Industry | Healthcare |
| CEO | Dr. Carl L.G. Hansen Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Tryn T. Stimart Esq., J.D., M.Sc. | Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer |
Graham Craig M.Sc. | Director of Corporate Development |
Caitlin Webster CIPD, M.Sc. | Director of Talent Development |
Dr. Carl L.G. Hansen Ph.D. | CEO, President & Chairperson |
Mr. Andrew Booth M.B.A. | Chief Financial Officer |
Dr. Veronique Lecault Ph.D. | CTO & Director |
Mr. Andrew Knowles M.Sc. | VP of Operations |
Marcie Thiessen CPA, CGA | Senior Director of Finance & Accounting |
Mr. Martin Hogan M.Sc. | Senior Director of Strategic Finance & IR |
Ms. Tiffany Chiu B.Sc., Ph.D. | Vice President of Communications |
Abcellera Biologics Inc share price today is $2.79 as on at the close of the market. Abcellera Biologics Inc share today touched a day high of $3.21 and a low of $2.75.
Abcellera Biologics Inc share touched a 52 week high of $6.52 on and a 52 week low of $1.89 on . Abcellera Biologics Inc stock price today i.e. is closed at $2.79,which is 57.18% down from its 52 week high and 47.57% up from its 52 week low.
Abcellera Biologics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Abcellera Biologics Inc (ABCL) shares with as little as ₹90.283 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.83 in Abcellera Biologics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Abcellera Biologics Inc share’s latest price of $2.79 as on February 6, 2026 at 2:29 am IST, you will get 3.5842 shares of Abcellera Biologics Inc. Learn more about
fractional shares .
Abcellera Biologics Inc stock has given -92.98% share price returns and 25.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?